THP1-Dual™ KO-IFNAR2 Cells

Product Unit size Cat. code Docs. Qty. Price

THP1-Dual™ KO-IFNAR2 Cells

Human THP-1 Monocytes - IFNAR2 knockout NF-κB-SEAP and IRF-Lucia Reporter Cells

Show product

3-7 x 10e6 cells


IFNAR2 knockout NF-κB-SEAP and IRF-Lucia luciferase reporter monocytes

THP1-Dual KO-IFNAR2 cells were generated from THP1-Dual cells by stable knockout of the IFNAR2 gene. They derive from human THP‑1 monocytes, a cell line often used to study DNA sensing pathways as they express all the cytosolic DNA sensors identified so far (with the exception of DAI).

THP1-Dual and THP1-Dual KO-IFNAR2 cells stably express two inducible secreted reporter genes: Lucia luciferase and SEAP (secreted embryonic alkaline phosphatase). The Lucia luciferase reporter gene is under the control of an ISG54 (interferon-stimulated gene) minimal promoter in conjunction with five IFN-stimulated response elements. The SEAP gene is driven by an IFN-β minimal promoter fused to five copies of the NF‑kB response element. As a result, they allow the simultaneous study of the IFN regulatory factor (IRF) pathway, by assessing the activity of Lucia luciferase and the NF-kB pathway, by monitoring the activity of SEAP. Both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI‑Luc™ 4 Lucia/Gaussia, a Lucia luciferase detection reagent, and QUANTI-Blue™, a SEAP detection reagent.

THP1-DualKO-IFNAR2 and THP1-Dualcells can be used to study the role of IFNAR2 by monitoring IRF-induced Lucia luciferase activity. THP1-Dual KO-IFNAR2 cells are resistant to blasticidin and Zeocin®.



1. Zao W. et al., 2008. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs. J Immunol. 180(8):5483-9.
2. de Weerd NA. et al., 2007. Type I interferon receptors: biochemistry and biological functions. J Biol Chem. 282(28):20053-7. 


IRF INDUCTION (Lucia luciferase reporter)
IRF INDUCTION (Lucia luciferase reporter)

Stimulation of THP1-Dual™ (parental cell line) and THP1-Dual™ KO-IFNAR cells with c-di-AMP (30 μg/ml), 2’3’-cGAMP (3 μg/ml), hIFN-β (1x104 U/ml), hIFN-α (1x104 U/ml), poly(dA:dT)/LyoVec™ (1 μg/ml), poly(I:C)/LyoVec™ (1 μg/ml), and VACV70/LyoVec™ (1 μg/ml). Human TNF-α (10 ng/ml) has been included as a negative control. After a 24h incubation, IRF activation was determined by measuring the relative light units (RLUs) in a luminometer using QUANTI-Luc™, a Lucia luciferase detection reagent. The IRF induction of each ligand is expressed relative to that of c-di-AMP at 30 μg/ml (taken as 100%).


THP1-Dual™ and THP1-Dual™ KO-IFNAR2 cells were incubated with human TNF-α (0.1 ng/ml), Pam3CSK4 (0.1 ng/ml; TLR1/2 ligand), LPS-EB Ultrapure (100 ng/ml; TLR4 ligand), VACV70/LyoVec™ (1 μg/ ml), poly(dA:dT)/LyoVec™ (100 ng/ml), 2’3’-cGAMP (3 μg/ml) and hIFN-α (1x104 U/ml). After a 24h incubation, NF-kB activation was determined using QUANTI-Blue™, a SEAP detection reagent, and by reading the optical density (OD) at 655 nm.

Back to the top


Antibiotic resistance: Zeocin®blasticidin

Growth medium: RPMI 1640, 2 mM L-glutamine, 25 mM HEPES, 10% heat-inactivated fetal bovine serum, 100 μg/ml Normocin™, Pen-Strep (100 U/ml-100 μg/ml)

Quality control
Biallelic IFNAR2 knockout is verified by functional assays, PCR and DNA sequencing.
These cells are guaranteed mycoplasma-free.

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top


  • 1 vial of THP1-Dual™ KO-IFNAR2 cells (3-7 x 106 cells) in freezing medium
  • 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria and fungi.
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

dry ice Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top


THP1 reporter cells are a family of cells derived from the human monocytic THP-1 cell line, which naturally expresses many pathogen recognition receptors (PRRs), including Toll-like receptors.

They respond to ligands for certain TLRs; namely, TLR2, TLR1/2, TLR2/6, TLR4, TLR5 and TLR8. These cells can also be used to study DNA sensing pathways, as they are highly responsive to PRR agonists that trigger interferon (IFN) signaling pathways.

THP1‑Dual™ cells feature two reporter genes that enable the simultaneous study of the NF-κB and IFN signaling pathways.

Type I interferons (IFNs), in particular IFN-α and IFN-β, are vital for host resistance to viral infections. Their activity is mediated by the IFN-α receptor (IFNAR), which consists of two chains: IFNAR1 and IFNAR2. Following their production, these cytokines bind IFNAR and recruit the Janus kinases (JAK1 and TyK2), leading to the phosphorylation of STAT1 and STAT2, which then dimerize. These dimers interact with IFN regulatory factor 9 (IRF9), forming a complex named ISGF3, which binds to IFN-stimulated response elements (ISRE) in the promoters of IFN-stimulated genes (ISG) to regulate their expression. Knockout of the IFNAR2 gene abolishes the cellular response to type I IFNs [1,2].

IFNAR2 Pathway

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification:  This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty